{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:06:16Z","timestamp":1789985176195,"version":"4.0.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["81125009"],"award-info":[{"award-number":["81125009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12035-015-9662-8","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T07:10:32Z","timestamp":1452150632000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Huntington\u2019s Disease: Relationship Between Phenotype and Genotype"],"prefix":"10.1007","volume":"54","author":[{"given":"Yi-Min","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"9662_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2310\/7010.2006.00055","volume":"21","author":"P Gonzalez-Alegre","year":"2006","unstructured":"Gonzalez-Alegre P, Afifi AK (2006) Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature. J Child Neurol 21:223\u20139","journal-title":"J Child Neurol"},{"key":"9662_CR2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-0004.2003.00108.x","volume":"64","author":"JM Milunsky","year":"2003","unstructured":"Milunsky JM, Maher TA, Loose BA, Darras BT, Ito M (2003) XL PCR for the detection of large trinucleotide expansions in juvenile Huntington\u2019s disease. Clin Genet 64:70\u20133","journal-title":"Clin Genet"},{"key":"9662_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ajmg.a.33911","volume":"155A","author":"G Nicolas","year":"2011","unstructured":"Nicolas G, Devys D, Goldenberg A, Maltete D, Herve C, Hannequin D, Guyant-Marechal L (2011) Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume. Am J Med Genet A 155A:815\u20138. doi: 10.1002\/ajmg.a.33911","journal-title":"Am J Med Genet A"},{"key":"9662_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. doi: 10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"9662_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher ER, Hayden MR (2014) Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Disord 29:105\u201314. doi: 10.1002\/mds.25717","journal-title":"Mov Disord"},{"key":"9662_CR6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/hmg\/3.12.2103","volume":"3","author":"F Squitieri","year":"1994","unstructured":"Squitieri F, Andrew SE, Goldberg YP, Kremer B, Spence N, Zeisler J, Nichol K, Theilmann J et al (1994) DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 3:2103\u201314","journal-title":"Hum Mol Genet"},{"key":"9662_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","volume":"84","author":"SC Warby","year":"2009","unstructured":"Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, Collins JA, Semaka A et al (2009) CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 84:351\u201366. doi: 10.1016\/j.ajhg.2009.02.003","journal-title":"Am J Hum Genet"},{"key":"9662_CR8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/301846","volume":"62","author":"The American College of Medical Genetics\/American Society of Human Genetics Huntington Disease Genetic Testing Working Group","year":"1998","unstructured":"The American College of Medical Genetics\/American Society of Human Genetics Huntington Disease Genetic Testing Working Group (1998) ACMG\/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 62:1243\u20137","journal-title":"Am J Hum Genet"},{"key":"9662_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4:387\u201392. doi: 10.1038\/ng0893-387","journal-title":"Nat Genet"},{"key":"9662_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/ene.12366","volume":"21","author":"H Jiang","year":"2014","unstructured":"Jiang H, Sun YM, Hao Y, Yan YP, Chen K, Xin SH, Tang YP, Li XH et al (2014) Huntingtin gene CAG repeat numbers in Chinese patients with Huntington\u2019s disease and controls. Eur J Neurol 21:637\u201342. doi: 10.1111\/ene.12366","journal-title":"Eur J Neurol"},{"key":"9662_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P et al (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690\u20135. doi: 10.1212\/WNL.0b013e318249f683","journal-title":"Neurology"},{"key":"9662_CR12","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A 101:3498\u2013503. doi: 10.1073\/pnas.0308679101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9662_CR13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.1995.00540320021009","volume":"52","author":"S Claes","year":"1995","unstructured":"Claes S, Van Zand K, Legius E, Dom R, Malfroid M, Baro F, Godderis J, Cassiman JJ (1995) Correlations between triplet repeat expansion and clinical features in Huntington\u2019s disease. Arch Neurol 52:749\u201353","journal-title":"Arch Neurol"},{"key":"9662_CR14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.31.11.872","volume":"31","author":"K Kieburtz","year":"1994","unstructured":"Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J et al (1994) Trinucleotide repeat length and progression of illness in Huntington\u2019s disease. J Med Genet 31:872\u20134","journal-title":"J Med Genet"},{"key":"9662_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ana.410390120","volume":"39","author":"S Furtado","year":"1996","unstructured":"Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A (1996) Relationship between trinucleotide repeats and neuropathological changes in Huntington\u2019s disease. Ann Neurol 39:132\u20136. doi: 10.1002\/ana.410390120","journal-title":"Ann Neurol"},{"key":"9662_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.46.2.527","volume":"46","author":"J Brandt","year":"1996","unstructured":"Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA (1996) Trinucleotide repeat length and clinical progression in Huntington\u2019s disease. Neurology 46:527\u201331","journal-title":"Neurology"},{"key":"9662_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41:689\u201392. doi: 10.1002\/ana.410410521","journal-title":"Ann Neurol"},{"key":"9662_CR18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","volume":"61","author":"N Mahant","year":"2003","unstructured":"Mahant N, McCusker EA, Byth K, Graham S (2003) Huntington\u2019s disease: clinical correlates of disability and progression. Neurology 61:1085\u201392","journal-title":"Neurology"},{"key":"9662_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt A, Liang KY, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA (2006) The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66:1016\u201320. doi: 10.1212\/01.wnl.0000204230.16619.d9","journal-title":"Neurology"},{"key":"9662_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/mds.21988","volume":"23","author":"B Ravina","year":"2008","unstructured":"Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP (2008) The relationship between CAG repeat length and clinical progression in Huntington\u2019s disease. Mov Disord 23:1223\u20137. doi: 10.1002\/mds.21988","journal-title":"Mov Disord"},{"key":"9662_CR21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jmg.30.12.996","volume":"30","author":"KE Rooij De","year":"1993","unstructured":"De Rooij KE, De Koning Gans PA, Skraastad MI, Belfroid RD, Vegter-Van Der Vlis M, Roos RA, Bakker E, Van Ommen GJ et al (1993) Dynamic mutation in Dutch Huntington\u2019s disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet 30:996\u20131002","journal-title":"J Med Genet"},{"key":"9662_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ng1093-174","volume":"5","author":"YP Goldberg","year":"1993","unstructured":"Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, Squitieri F, Telenius H, Adam S et al (1993) Molecular analysis of new mutations for Huntington\u2019s disease: intermediate alleles and sex of origin effects. Nat Genet 5:174\u20139. doi: 10.1038\/ng1093-174","journal-title":"Nat Genet"},{"key":"9662_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/ajmg.a.32901","volume":"149A","author":"AE Hendricks","year":"2009","unstructured":"Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Wheeler V, MacDonald ME, Gusella JF, Myers RH (2009) Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27\u201335 CAG). Am J Med Genet A 149A:1375\u201381. doi: 10.1002\/ajmg.a.32901","journal-title":"Am J Med Genet A"},{"key":"9662_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/jmedgenet-2013-101796","volume":"50","author":"A Semaka","year":"2013","unstructured":"Semaka A, Kay C, Doty C, Collins JA, Bijlsma EK, Richards F, Goldberg YP, Hayden MR (2013) CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet 50:696\u2013703. doi: 10.1136\/jmedgenet-2013-101796","journal-title":"J Med Genet"},{"key":"9662_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1399-0004.2010.01388.x","volume":"78","author":"J Sequeiros","year":"2010","unstructured":"Sequeiros J, Ramos EM, Cerqueira J, Costa MC, Sousa A, Pinto-Basto J, Alonso I (2010) Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet 78:381\u20137. doi: 10.1111\/j.1399-0004.2010.01388.x","journal-title":"Clin Genet"},{"key":"9662_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.b.30826","volume":"150B","author":"D Brocklebank","year":"2009","unstructured":"Brocklebank D, Gayan J, Andresen JM, Roberts SA, Young AB, Snodgrass SR, Penney JB, Ramos-Arroyo MA et al (2009) Repeat instability in the 27\u201339 CAG range of the HD gene in the Venezuelan kindreds: counseling implications. Am J Med Genet B Neuropsychiatr Genet 150B:425\u20139. doi: 10.1002\/ajmg.b.30826","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9662_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/mds.21958","volume":"23","author":"J Andrich","year":"2008","unstructured":"Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C (2008) Huntington\u2019s disease as caused by 34 CAG repeats. Mov Disord 23:879\u201381. doi: 10.1002\/mds.21958","journal-title":"Mov Disord"},{"key":"9662_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/jnnp.2008.170902","volume":"81","author":"JL Groen","year":"2010","unstructured":"Groen JL, de Bie RM, Foncke EM, Roos RA, Leenders KL, Tijssen MA (2010) Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry 81:228\u201330. doi: 10.1136\/jnnp.2008.170902","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9662_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3810\/pgm.2011.09.2466","volume":"123","author":"AD Ha","year":"2011","unstructured":"Ha AD, Jankovic J (2011) Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med 123:116\u201321. doi: 10.3810\/pgm.2011.09.2466","journal-title":"Postgrad Med"},{"key":"9662_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2008.11.005","volume":"277","author":"YO Herishanu","year":"2009","unstructured":"Herishanu YO, Parvari R, Pollack Y, Shelef I, Marom B, Martino T, Cannella M, Squitieri F (2009) Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? J Neurol Sci 277:143\u20136. doi: 10.1016\/j.jns.2008.11.005","journal-title":"J Neurol Sci"},{"key":"9662_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mds.21195","volume":"22","author":"C Kenney","year":"2007","unstructured":"Kenney C, Powell S, Jankovic J (2007) Autopsy-proven Huntington\u2019s disease with 29 trinucleotide repeats. Mov Disord 22:127\u201330. doi: 10.1002\/mds.21195","journal-title":"Mov Disord"},{"key":"9662_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/mds.23623","volume":"26","author":"F Squitieri","year":"2011","unstructured":"Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J (2011) Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington\u2019s disease gene. Mov Disord 26:925\u20137. doi: 10.1002\/mds.23623","journal-title":"Mov Disord"},{"key":"9662_CR33","unstructured":"Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M et al (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59(1):16\u201322"},{"key":"9662_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","volume":"80","author":"A Killoran","year":"2013","unstructured":"Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I (2013) Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology 80:2022\u20137. doi: 10.1212\/WNL.0b013e318294b304","journal-title":"Neurology"},{"key":"9662_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jns.2010.11.015","volume":"301","author":"PK Panegyres","year":"2011","unstructured":"Panegyres PK, Goh JG (2011) The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene. J Neurol Sci 301:14\u201320. doi: 10.1016\/j.jns.2010.11.015","journal-title":"J Neurol Sci"},{"key":"9662_CR36","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1136\/jmg.2006.045120","volume":"44","author":"OW Quarrell","year":"2007","unstructured":"Quarrell OW, Rigby AS, Barron L, Crow Y, Dalton A, Dennis N, Fryer AE, Heydon F et al (2007) Reduced penetrance alleles for Huntington\u2019s disease: a multi-centre direct observational study. J Med Genet 44:e68. doi: 10.1136\/jmg.2006.045120","journal-title":"J Med Genet"},{"key":"9662_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajmg.b.30261","volume":"141B","author":"Y Tang","year":"2006","unstructured":"Tang Y, Wang Y, Yang P, Liu Y, Wang B, Podolsky R, McIndoe R, Wang CY (2006) Intergeneration CAG expansion and contraction in a Chinese HD family. Am J Med Genet B Neuropsychiatr Genet 141B:242\u20134. doi: 10.1002\/ajmg.b.30261","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9662_CR38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/hmg\/ddn003","volume":"17","author":"S Metzger","year":"2008","unstructured":"Metzger S, Rong J, Nguyen HP, Cape A, Tomiuk J, Soehn AS, Propping P, Freudenberg-Hua Y et al (2008) Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington\u2019s disease. Hum Mol Genet 17:1137\u201346. doi: 10.1093\/hmg\/ddn003","journal-title":"Hum Mol Genet"},{"key":"9662_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.parkreldis.2012.05.020","volume":"18","author":"G Karadima","year":"2012","unstructured":"Karadima G, Dimovasili C, Koutsis G, Vassilopoulos D, Panas M (2012) Age at onset in Huntington\u2019s disease: replication study on the association of HAP1. Parkinsonism Relat Disord 18:1027\u20138. doi: 10.1016\/j.parkreldis.2012.05.020","journal-title":"Parkinsonism Relat Disord"},{"key":"9662_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1326-4-10","volume":"4","author":"E Taherzadeh-Fard","year":"2009","unstructured":"Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10. doi: 10.1186\/1750-1326-4-10","journal-title":"Mol Neurodegener"},{"key":"9662_CR41","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1523\/JNEUROSCI.20-06-02175.2000","volume":"20","author":"K Chergui","year":"2000","unstructured":"Chergui K, Bouron A, Normand E, Mulle C (2000) Functional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmission. J Neurosci 20:2175\u201382","journal-title":"J Neurosci"},{"key":"9662_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.nbd.2003.12.010","volume":"15","author":"E Diguet","year":"2004","unstructured":"Diguet E, Fernagut PO, Normand E, Centelles L, Mulle C, Tison F (2004) Experimental basis for the putative role of GluR6\/kainate glutamate receptor subunit in Huntington\u2019s disease natural history. Neurobiol Dis 15:667\u201375. doi: 10.1016\/j.nbd.2003.12.010","journal-title":"Neurobiol Dis"},{"key":"9662_CR43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.53.6.1330","volume":"53","author":"ME MacDonald","year":"1999","unstructured":"MacDonald ME, Vonsattel JP, Shrinidhi J, Couropmitree NN, Cupples LA, Bird ED, Gusella JF, Myers RH (1999) Evidence for the GluR6 gene associated with younger onset age of Huntington\u2019s disease. Neurology 53:1330\u20132","journal-title":"Neurology"},{"key":"9662_CR44","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.94.8.3872","volume":"94","author":"DC Rubinsztein","year":"1997","unstructured":"Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D (1997) Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A 94:3872\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9662_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jmg.2006.045153","volume":"44","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gayan J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, Group US-VCR, Cardon LR et al (2007) Replication of twelve association studies for Huntington\u2019s disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44\u201350. doi: 10.1136\/jmg.2006.045153","journal-title":"J Med Genet"},{"key":"9662_CR46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","volume":"35","author":"CM Dhaenens","year":"2009","unstructured":"Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I et al (2009) A genetic variation in the ADORA2A gene modifies age at onset in Huntington\u2019s disease. Neurobiol Dis 35:474\u20136. doi: 10.1016\/j.nbd.2009.06.009","journal-title":"Neurobiol Dis"},{"key":"9662_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S et al (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol 8:9. doi: 10.1186\/1471-2377-8-9","journal-title":"BMC Neurol"},{"key":"9662_CR48","first-page":"108","volume":"36","author":"P Kehoe","year":"1999","unstructured":"Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL (1999) Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 36:108\u201311","journal-title":"J Med Genet"},{"key":"9662_CR49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s004150050406","volume":"246","author":"M Panas","year":"1999","unstructured":"Panas M, Avramopoulos D, Karadima G, Petersen MB, Vassilopoulos D (1999) Apolipoprotein E and presenilin-1 genotypes in Huntington\u2019s disease. J Neurol 246:574\u20137","journal-title":"J Neurol"},{"key":"9662_CR50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0197-4580(00)00150-0","volume":"21","author":"J Kalman","year":"2000","unstructured":"Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, Gardian G, Rasko I, Janka Z (2000) Apolipoprotein E polymorphism in Pick\u2019s disease and in Huntington\u2019s disease. Neurobiol Aging 21:555\u20138","journal-title":"Neurobiol Aging"},{"key":"9662_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000093867","volume":"55","author":"PK Panegyres","year":"2006","unstructured":"Panegyres PK, Beilby J, Bulsara M, Toufexis K, Wong C (2006) A study of potential interactive genetic factors in Huntington\u2019s disease. Eur Neurol 55:189\u201392. doi: 10.1159\/000093867","journal-title":"Eur Neurol"},{"key":"9662_CR52","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/jnnp.2003.022756","volume":"75","author":"C Saft","year":"2004","unstructured":"Saft C, Andrich JE, Brune N, Gencik M, Kraus PH, Przuntek H, Epplen JT (2004) Apolipoprotein E genotypes do not influence the age of onset in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 75:1692\u20136. doi: 10.1136\/jnnp.2003.022756","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9662_CR53","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1073\/pnas.041566798","volume":"98","author":"S Holbert","year":"2001","unstructured":"Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA et al (2001) The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington\u2019s disease pathogenesis. Proc Natl Acad Sci U S A 98:1811\u20136. doi: 10.1073\/pnas.041566798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9662_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00439-010-0873-9","volume":"128","author":"S Metzger","year":"2010","unstructured":"Metzger S, Saukko M, Van Che H, Tong L, Puder Y, Riess O, Nguyen HP (2010) Age at onset in Huntington\u2019s disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7. Hum Genet 128:453\u20139. doi: 10.1007\/s00439-010-0873-9","journal-title":"Hum Genet"},{"key":"9662_CR55","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/hmg\/dds177","volume":"21","author":"SM Soyal","year":"2012","unstructured":"Soyal SM, Felder TK, Auer S, Hahne P, Oberkofler H, Witting A, Paulmichl M, Landwehrmeyer GB et al (2012) A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet 21:3461\u201373. doi: 10.1093\/hmg\/dds177","journal-title":"Hum Mol Genet"},{"key":"9662_CR56","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jocn.2009.03.027","volume":"16","author":"EH Xu","year":"2009","unstructured":"Xu EH, Tang Y, Li D, Jia JP (2009) Polymorphism of HD and UCHL-1 genes in Huntington\u2019s disease. J Clin Neurosci 16:1473\u20137. doi: 10.1016\/j.jocn.2009.03.027","journal-title":"J Clin Neurosci"},{"key":"9662_CR57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejmg.2013.05.007","volume":"56","author":"E Kloster","year":"2013","unstructured":"Kloster E, Saft C, Epplen JT, Arning L (2013) CNR1 variation is associated with the age at onset in Huntington disease. Eur J Med Genet 56:416\u20139. doi: 10.1016\/j.ejmg.2013.05.007","journal-title":"Eur J Med Genet"},{"key":"9662_CR58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/378133","volume":"73","author":"JL Li","year":"2003","unstructured":"Li JL, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dode C, Morrison PJ, Suchowersky O et al (2003) A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet 73:682\u20137. doi: 10.1086\/378133","journal-title":"Am J Hum Genet"},{"key":"9662_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2350-7-71","volume":"7","author":"JL Li","year":"2006","unstructured":"Li JL, Hayden MR, Warby SC, Durr A, Morrison PJ, Nance M, Ross CA, Margolis RL et al (2006) Genome-wide significance for a modifier of age at neurological onset in Huntington\u2019s disease at 6q23-24: the HD MAPS study. BMC Med Genet 7:71. doi: 10.1186\/1471-2350-7-71","journal-title":"BMC Med Genet"},{"key":"9662_CR60","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/gepi.20317","volume":"32","author":"J Gayan","year":"2008","unstructured":"Gayan J, Brocklebank D, Andresen JM, Alkorta-Aranburu G, Zameel Cader M, Roberts SA, Cherny SS, Wexler NS et al (2008) Genomewide linkage scan reveals novel loci modifying age of onset of Huntington\u2019s disease in the Venezuelan HD kindreds. Genet Epidemiol 32:445\u201353. doi: 10.1002\/gepi.20317","journal-title":"Genet Epidemiol"},{"key":"9662_CR61","doi-asserted-by":"publisher","unstructured":"Genetic Modifiers of Huntington\u2019s Disease C (2015) Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162:516\u201326. doi: 10.1016\/j.cell.2015.07.003","DOI":"10.1016\/j.cell.2015.07.003"},{"key":"9662_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/gm80","volume":"1","author":"JF Gusella","year":"2009","unstructured":"Gusella JF, MacDonald ME (2009) Huntington\u2019s disease: the case for genetic modifiers. Genome Med 1:80. doi: 10.1186\/gm80","journal-title":"Genome Med"},{"key":"9662_CR63","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mds.26001","volume":"29","author":"JF Gusella","year":"2014","unstructured":"Gusella JF, MacDonald ME, Lee JM (2014) Genetic modifiers of Huntington\u2019s disease. Mov Disord 29:1359\u201365. doi: 10.1002\/mds.26001","journal-title":"Mov Disord"},{"key":"9662_CR64","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nature14618","volume":"523","author":"PK Joshi","year":"2015","unstructured":"Joshi PK, Esko T, Mattsson H, Eklund N, Gandin I, Nutile T, Jackson AU, Schurmann C et al (2015) Directional dominance on stature and cognition in diverse human populations. Nature 523:459\u201362. doi: 10.1038\/nature14618","journal-title":"Nature"},{"key":"9662_CR65","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jmb.2005.10.053","volume":"355","author":"A Bhattacharyya","year":"2006","unstructured":"Bhattacharyya A, Thakur AK, Chellgren VM, Thiagarajan G, Williams AD, Chellgren BW, Creamer TP, Wetzel R (2006) Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol 355:524\u201335. doi: 10.1016\/j.jmb.2005.10.053","journal-title":"J Mol Biol"},{"key":"9662_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, Sullivan PG, Steffan JS et al (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16:61\u201377. doi: 10.1093\/hmg\/ddl440","journal-title":"Hum Mol Genet"},{"key":"9662_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.arcmed.2007.06.015","volume":"39","author":"S Morovvati","year":"2008","unstructured":"Morovvati S, Nakagawa M, Osame M, Karami A (2008) Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan. Arch Med Res 39:131\u20133. doi: 10.1016\/j.arcmed.2007.06.015","journal-title":"Arch Med Res"},{"key":"9662_CR68","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.64.6.758","volume":"64","author":"I Vuillaume","year":"1998","unstructured":"Vuillaume I, Vermersch P, Destee A, Petit H, Sablonniere B (1998) Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 64:758\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9662_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2011.08.015","volume":"312","author":"BR Zhang","year":"2012","unstructured":"Zhang BR, Tian J, Yan YP, Yin XZ, Zhao GH, Wu ZY, Gu WH, Xia K et al (2012) CCG polymorphisms in the huntingtin gene have no effect on the pathogenesis of patients with Huntington\u2019s disease in mainland Chinese families. J Neurol Sci 312:92\u20136. doi: 10.1016\/j.jns.2011.08.015","journal-title":"J Neurol Sci"},{"key":"9662_CR70","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/jhg.2012.120","volume":"57","author":"A Agostinho Lde","year":"2012","unstructured":"Agostinho Lde A, Rocha CF, Medina-Acosta E, Barboza HN, da Silva AF, Pereira SP, da Silva IS, Paradela ER et al (2012) Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington\u2019s disease. J Hum Genet 57:796\u2013803. doi: 10.1038\/jhg.2012.120","journal-title":"J Hum Genet"},{"key":"9662_CR71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jmg.32.9.701","volume":"32","author":"N Masuda","year":"1995","unstructured":"Masuda N, Goto J, Murayama N, Watanabe M, Kondo I, Kanazawa I (1995) Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington\u2019s disease. J Med Genet 32:701\u20135","journal-title":"J Med Genet"},{"key":"9662_CR72","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.ejhg.5200515","volume":"8","author":"S Pramanik","year":"2000","unstructured":"Pramanik S, Basu P, Gangopadhaya PK, Sinha KK, Jha DK, Sinha S, Das SK, Maity BK et al (2000) Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India. Eur J Hum Genet 8:678\u201382. doi: 10.1038\/sj.ejhg.5200515","journal-title":"Eur J Hum Genet"},{"key":"9662_CR73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0404.2003.00133.x","volume":"108","author":"Q Saleem","year":"2003","unstructured":"Saleem Q, Roy S, Murgood U, Saxena R, Verma IC, Anand A, Muthane U, Jain S et al (2003) Molecular analysis of Huntington\u2019s disease and linked polymorphisms in the Indian population. Acta Neurol Scand 108:281\u20136","journal-title":"Acta Neurol Scand"},{"key":"9662_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12120","author":"ZJ Liu","year":"2013","unstructured":"Liu ZJ, Sun YM, Ni W, Dong Y, Shi SS, Wu ZY (2013) Clinical features of Chinese patients with Huntington\u2019s disease carrying CAG repeats beyond 60 within HTT gene. Clin Genet. doi: 10.1111\/cge.12120","journal-title":"Clin Genet"},{"key":"9662_CR75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.57.2.99","volume":"57","author":"JP Osborne","year":"1982","unstructured":"Osborne JP, Munson P, Burman D (1982) Huntington\u2019s chorea. Report of 3 cases and review of the literature. Arch Dis Child 57:99\u2013103","journal-title":"Arch Dis Child"},{"key":"9662_CR76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u201373","journal-title":"ILAR J"},{"key":"9662_CR77","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O (2006) Juvenile Huntington\u2019s disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease? Mech Ageing Dev 127:208\u201312. doi: 10.1016\/j.mad.2005.09.012","journal-title":"Mech Ageing Dev"},{"key":"9662_CR78","first-page":"593","volume":"57","author":"NG Ranen","year":"1995","unstructured":"Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS et al (1995) Anticipation and instability of IT-15 (CAG) n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57:593\u2013602","journal-title":"Am J Hum Genet"},{"key":"9662_CR79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/WNL.52.2.392","volume":"52","author":"MA Nance","year":"1999","unstructured":"Nance MA, Mathias-Hagen V, Breningstall G, Wick MJ, McGlennen RC (1999) Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington\u2019s disease. Neurology 52:392\u20134","journal-title":"Neurology"},{"key":"9662_CR80","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s004390050432","volume":"99","author":"K Sathasivam","year":"1997","unstructured":"Sathasivam K, Amaechi I, Mangiarini L, Bates G (1997) Identification of an HD patient with a (CAG) 180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage. Hum Genet 99:692\u20135","journal-title":"Hum Genet"},{"key":"9662_CR81","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00431-004-1537-3","volume":"163","author":"S Seneca","year":"2004","unstructured":"Seneca S, Fagnart D, Keymolen K, Lissens W, Hasaerts D, Debulpaep S, Desprechins B, Liebaers I et al (2004) Early onset Huntington disease: a neuronal degeneration syndrome. Eur J Pediatr 163:717\u201321. doi: 10.1007\/s00431-004-1537-3","journal-title":"Eur J Pediatr"},{"key":"9662_CR82","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","volume":"2","author":"H Telenius","year":"1993","unstructured":"Telenius H, Kremer HP, Theilmann J, Andrew SE, Almqvist E, Anvret M, Greenberg C, Greenberg J et al (1993) Molecular analysis of juvenile Huntington disease: the major influence on (CAG) n repeat length is the sex of the affected parent. Hum Mol Genet 2:1535\u201340","journal-title":"Hum Mol Genet"},{"key":"9662_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mrdd.1022","volume":"7","author":"MA Nance","year":"2001","unstructured":"Nance MA, Myers RH (2001) Juvenile onset Huntington\u2019s disease\u2014clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7:153\u20137. doi: 10.1002\/mrdd.1022","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"9662_CR84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, Adam S, Greenberg C et al (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet 6:409\u201314. doi: 10.1038\/ng0494-409","journal-title":"Nat Genet"},{"key":"9662_CR85","first-page":"343","volume":"57","author":"B Kremer","year":"1995","unstructured":"Kremer B, Almqvist E, Theilmann J, Spence N, Telenius H, Goldberg YP, Hayden MR (1995) Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet 57:343\u201350","journal-title":"Am J Hum Genet"},{"key":"9662_CR86","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1399-0004.2000.580108.x","volume":"58","author":"F Squitieri","year":"2000","unstructured":"Squitieri F, Berardelli A, Nargi E, Castellotti B, Mariotti C, Cannella M, Lavitrano ML, de Grazia U et al (2000) Atypical movement disorders in the early stages of Huntington\u2019s disease: clinical and genetic analysis. Clin Genet 58:50\u20136","journal-title":"Clin Genet"},{"key":"9662_CR87","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1399-0004.2012.01927.x","volume":"83","author":"Y Dong","year":"2013","unstructured":"Dong Y, Sun YM, Liu ZJ, Ni W, Shi SS, Wu ZY (2013) Chinese patients with Huntington\u2019s disease initially presenting with spinocerebellar ataxia. Clin Genet 83:380\u20133. doi: 10.1111\/j.1399-0004.2012.01927.x","journal-title":"Clin Genet"},{"key":"9662_CR88","first-page":"172","volume":"36","author":"A Durr","year":"1999","unstructured":"Durr A, Hahn-Barma V, Brice A, Pecheux C, Dode C, Feingold J (1999) Homozygosity in Huntington\u2019s disease. J Med Genet 36:172\u20133","journal-title":"J Med Genet"},{"key":"9662_CR89","first-page":"615","volume":"45","author":"RH Myers","year":"1989","unstructured":"Myers RH, Leavitt J, Farrer LA, Jagadeesh J, McFarlane H, Mastromauro CA, Mark RJ, Gusella JF (1989) Homozygote for Huntington disease. Am J Hum Genet 45:615\u20138","journal-title":"Am J Hum Genet"},{"key":"9662_CR90","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/326194a0","volume":"326","author":"NS Wexler","year":"1987","unstructured":"Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, Snodgrass SR, Shoulson I et al (1987) Homozygotes for Huntington\u2019s disease. Nature 326:194\u20137. doi: 10.1038\/326194a0","journal-title":"Nature"},{"key":"9662_CR91","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin B et al (1994) A worldwide study of the Huntington\u2019s disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med 330:1401\u20136. doi: 10.1056\/NEJM199405193302001","journal-title":"N Engl J Med"},{"key":"9662_CR92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1034\/j.1399-0004.2002.610607.x","volume":"61","author":"ME Alonso","year":"2002","unstructured":"Alonso ME, Yescas P, Rasmussen A, Ochoa A, Macias R, Ruiz I, Suastegui R (2002) Homozygosity in Huntington\u2019s disease: new ethical dilemma caused by molecular diagnosis. Clin Genet 61:437\u201342","journal-title":"Clin Genet"},{"key":"9662_CR93","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D et al (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126:946\u201355","journal-title":"Brain"},{"key":"9662_CR94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrd1077","volume":"1","author":"JF Gusella","year":"2000","unstructured":"Gusella JF, MacDonald ME (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1:109\u201315. doi: 10.1038\/nrd1077","journal-title":"Nat Rev Neurosci"},{"key":"9662_CR95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000472162","volume":"4","author":"I Lerer","year":"1996","unstructured":"Lerer I, Merims D, Abeliovich D, Zlotogora J, Gadoth N (1996) Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Hum Genet 4:3\u20137","journal-title":"Eur J Hum Genet"},{"key":"9662_CR96","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1212\/WNL.45.10.1934","volume":"45","author":"K Sato","year":"1995","unstructured":"Sato K, Kashihara K, Okada S, Ikeuchi T, Tsuji S, Shomori T, Morimoto K, Hayabara T (1995) Does homozygosity advance the onset of dentatorubral-pallidoluysian atrophy? Neurology 45:1934\u20136","journal-title":"Neurology"},{"key":"9662_CR97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp.60.3.354-a","volume":"60","author":"G Sobue","year":"1996","unstructured":"Sobue G, Doyu M, Nakao N, Shimada N, Mitsuma T, Maruyama H, Kawakami S, Nakamura S (1996) Homozygosity for Machado-Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry 60:354\u20136","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9662_CR98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/YPG.0b013e328347c203","volume":"22","author":"SS Shi","year":"2012","unstructured":"Shi SS, Lin Y, Zhao GX, Gan SR, Wu ZY (2012) A Chinese pedigree with an individual homozygous for CAG repeats of Huntington\u2019s disease. Psychiatr Genet 22:53\u20134. doi: 10.1097\/YPG.0b013e328347c203","journal-title":"Psychiatr Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9662-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9662-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T02:38:22Z","timestamp":1654051102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9662-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9662"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9662-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}